红花石蒜苯丙氨酸解氨酶催化合成N-甲基-L-苯丙氨酸（英文）

【背景】N-甲基-L-苯丙氨酸是一种N-烷基化芳香氨基酸,是重要的手性合成单元/中间体/组成成分,在医药、农业、食品等领域有重要应用价值的代谢产物中广泛存在。N-烷基化芳香氨基酸的合成与制备仍具有巨大的挑战。【目的】在研究加兰他敏的生物合成过程中,我们从产加兰他敏的红花石蒜中克隆并表征苯丙氨酸解氨酶LrPAL3。LrPAL3催化区域及对映选择性的氢胺化反应得到L-苯丙氨酸。通过生物信息学分析,推测LrPAL3可能催化反式-肉桂酸的一步N-甲基胺化反应得到N-甲基-L-苯丙氨酸。【方法】将反式-肉桂酸与甲胺,以及表达LrPAL3的大肠杆菌全细胞一起孵育。HPLC-DAD及HRESIMS分析表明,上述反应产物为N-甲基-苯丙氨酸。为确定该产物的立体构型,将上述催化反应放大,通过分离纯化得到该酶催化反应产物。【结果】该化合物的氢谱数据及比旋光数据与N-甲基-L-苯丙氨酸标准品的数据一致。由此说明,LrPAL3能够催化反式-肉桂酸和甲胺发生N-烷基胺化反应,区域和立体专一性地生成N-甲基-L-苯丙氨酸。【结论】本研究为手性N-烷基氨基酸的不对称合成提供了一种全新的绿色、高效生物催化剂。通过对LrPAL3的蛋白质定向进化及代谢工程,将会进一步扩展LrPAL3的催化反应范围,以多种N-烷基胺类及取代的苯基丙烯酸为底物,实现手性N-烷基-芳基氨基酸的高效区域及立体选择性生物合成。     

YPS1/YPS2失活改进酿酒酵母An-α菌株β-葡萄糖苷酶分泌表达

[背景] 工业酵母菌株的蛋白质表达通常存在表达量低、分泌效率低的问题。[目的] 考察失活Yapsin蛋白酶Yps1p和Yps2p对β-葡萄糖苷酶在酿酒酵母An-α菌株中表达的影响。[方法] 利用CRISPR/Cas9基因组编辑技术,首先构建得到未折叠蛋白响应（Unfolded Protein Response,UPR）指示菌株An-α（leu2：：UPRE-lacZ）即An-αL,然后分别失活其YPS1和YPS2基因,导入以YEplac195为载体的β-葡萄糖苷酶表达质粒（简称BG）,进行生长和酶活分析评价。[结果] 菌株An-αL的YPS1和YPS2基因失活对其在酵母浸出粉胨葡萄糖（Yeast Extract Peptone Dextrose,YPD）培养基中的生长未造成明显的不利影响;导入质粒BG后将在酵母浸出粉胨纤维二糖（Yeast Extract Peptone Cellobiose,YPC）培养基中生长的最大OD₆₀₀分别提高了21.9%和7.4%;最大总酶活值为0.087 5和0.068 6 U/（mL·OD₆₀₀）,是对照菌株相应值的2.268倍和1.778倍;分泌比例提高了19.4%和22.2%;β-葡萄糖苷酶表达水平与β-半乳糖苷酶酶活水平所代表的UPR信号响应值之间呈现良好的相关性。[结论] YPS1和YPS2基因失活有助于改进酿酒酵母An-α菌株中β-葡萄糖苷酶的分泌表达。     

多酶融合表达体系以木聚糖为辅助底物高效合成(S)-苯乙二醇

[目的] 利用木聚糖为辅助底物加强手性催化反应中的辅酶循环,构建来源于近平滑假丝酵母（Candida parapsilosis）CCTCC M203011的（S）-羰基还原酶II（SCRII）、枯草芽孢杆菌（Bacillussp.）YX-1葡萄糖脱氢酶突变体Ala258Phe/GDH和里氏木霉（Trichoderma reesei）Rut C-30木聚糖酶（XYN2）在大肠杆菌（Escherichia coli）BL21（DE3）中的融合表达体系,高效合成（S）-苯乙二醇。[方法] 调节3种酶编码基因在pET-28a载体上的位置,运用重叠延伸PCR技术,构建了E.coli/pET-SCRII-A258F-XYN2和E.coli/pET-A258F-SCRII-XYN2两种重组菌,研究了其合成（S）-苯乙二醇的最适反应条件。[结果] 重组菌株E.coli/pET-SCRII-A258F-XYN2在底物2-羟基苯乙酮与辅助底物木聚糖的比例为1：1、35℃、pH为7.0条件下,（S）-苯乙二醇的产率达98.8%（W/W）;而重组菌株E.coli/pET-A258F-SCRII-XYN2在底物与辅助底物的比例为2：1、35℃、pH为7.0条件下,（S）-苯乙二醇的产率达95.6%（W/W）,两者合成产物的光学纯度均>99%。[结论] 通过构建3种酶的融合表达体系,成功将木聚糖酶和葡萄糖脱氢酶突变体介导的辅酶再生循环体系引入不对称生物合成反应,提高了手性转化效率,为将大自然中丰富的木聚糖用于手性催化奠定了较扎实的研究基础。     

利用大肠埃希菌生产N-糖基化重组蛋白研究进展

利用大肠埃希菌生产N-糖基化重组蛋白已经成为糖工程研究热点之一。由于真核生物系统生产N-糖基化蛋白普遍存在培养周期长、过程复杂及所需成本高的问题,因此遗传背景清晰、培养周期短、所需成本低的大肠埃希菌作为生产蛋白质药物的工具越来越受到关注,在生产治疗性N-糖基化蛋白方面具有很大的潜力。本文介绍了大肠埃希菌生产N-糖基化重组蛋白的机制,综述了利用大肠埃希菌生产N-糖基化重组蛋白及糖疫苗的研究进展,对值得进一步深入研究的问题进行总结和展望,以期为后续构建稳定高效的大肠埃希菌生产N-糖基化重组蛋白系统提供参考。     

马源马链球菌兽疫亚种3株新疆分离株基因型的鉴定及MLST分析

[背景] 马链球菌兽疫亚种（Streptococcus equi subsp. zooepidemicus,SeZ）是引起马腺疫的主要病原,还可引起猪链球菌病,加强该菌的地方株分子流行病学监测对有效防控相关疫病十分必要。[目的] 对新疆地区2个马场SeZ分离株进行鉴定和药敏特性分析,并分析3株新疆分离株的分子流行与菌株的遗传进化特征。[方法] 对分离纯化的3株病原菌（ZHZ113、ZHZ211和ZHZ523）进行染色观察、生化及药敏特性检测,对16S rRNA和SeM基因进行遗传进化分析,以链球菌7个管家基因arcC、nrdE、proS、spi、tdk、tpi和yqiL为目的基因对3株分离菌进行多位点序列分型（Multilocus Sequence Typing,MLST）研究。[结果] 3株SeZ的药敏结果显示这3株分离菌对不同抗生素的耐药程度不同,但均对头孢西丁、庆大霉素、链霉素、红霉素、左氧氟沙星、环丙沙星、土霉素等11种药物敏感。16S rRNA基因序列分析显示这3株分离菌均属于Ⅱ群（兽疫链球菌）。3株菌的MLST分型结果分别为ST39、ST419、ST421型,其中ST419和ST421型为SeZ目前尚未见报道的新ST型。SeM基因分析结果显示马源SeZ在不同国家、不同动物和不同时间段上的流行分布存在差异和动态变化的特点。[结论] 3株SeZ分离菌分别与美国犬源及马源菌株亲缘关系较近,反映部分SeZ株在新疆地区的基因型分布及分子流行特点。     

红树林土壤中产聚羟基脂肪酸酯细菌的分离及其评估

[背景] 细菌能通过合成聚羟基脂肪酸酯（Polyhydroxyalknoates,PHA）在细胞内储存物质和能量,提高对环境的适应能力。在红树林中,由于土壤周期性受海水浸没,形成营养物质种类丰富和含量波动大的特殊生境,为细菌进化出特殊的PHA合成途径提供了条件。[目标] 为了增加对红树林产PHA细菌资源的了解,获得产PHA细菌,使用纯培养方法分离和鉴定细菌,并评估菌株的产PHA能力。[方法] 采集红树植物海桑根系和红树滩涂土壤样品,连续5周培养、分离纯化获得细菌菌株;通过16S rRNA基因相似性及系统进化分析鉴定细菌分类地位,利用PHA合成酶基因（phaC）鉴定细菌合成PHA的能力;通过基因组草图测序,分析细菌的phaC基因种类、代谢通路及系统进化关系;通过气相色谱分析细菌产PHA的累积量及组成。[结果] 从红树林土壤样品中分离得到97株细菌,其中13株带有phaC基因,包括坚强芽孢杆菌（Cytobacillus firmus）、弯曲芽孢杆菌（Bacillus flexus）、除烃海杆菌（Marinobacter hydrocarbonoclasticus）和酯香微杆菌（Microbacterium esteraromaticum）。B. flexus MN15-19以丙酮酸盐为碳源,可累积细胞干重11%的PHA,同时具有固碳功能的还原性三羧酸循环通路,有开发成为固碳产PHA工程菌株的潜力。酯香微杆菌可产PHA,但是其phaC基因结构特殊,基因组注释未能识别出任何已知phaC基因。[结论] 研究发现红树林土壤可培养细菌中存在未知的PHA合成途径,说明红树林生态系统中的细菌具有资源挖掘的重要价值。     

利用含油培养基富集、分离和评估海洋产聚羟基脂肪酸酯细菌

[背景] 细菌可通过脂肪酸代谢途径耦合聚羟基脂肪酸酯（Polyhydroxyalkanoate,PHA）合成途径实现合成中长链PHA;其拉伸强度、玻璃化温度等加工特性均优于短链PHA,是未来工业化PHA材料的发展方向。[目标] 为了获得新的可代谢油类的产PHA细菌,使用3种分离策略从海洋沉积物中分离和鉴定细菌,并评估菌株产PHA的能力。[方法] 采集深圳大鹏湾近海沉积物样品;样品通过直接分离,5周连续培养分离,或10周连续提高盐度（3.5%-12.5%）和含油量（1%-10%）富集培养分离,纯化得到菌株;通过16S rRNA基因相似性及系统进化分析鉴定细菌分类地位,利用PHA聚合酶（PhaC）基因鉴定细菌合成PHA的能力;通过测定基因组框架图,分析细菌的PhaC类型、代谢通路及系统进化关系;通过气相色谱分析细菌产PHA的含量及组成。[结果] 从深圳大鹏湾近海底泥样品中分离得到96株细菌,phaC基因阳性率达38%,其中包含9个此前未通过产物证实可产PHA的属,包括尖球菌属（Acuticoccus）、海洋源菌属（Idiomarina）、盐芽孢杆菌属（Halobacillus）、微泡菌属（Microbulbifer）、海棍状菌属（Maritimibacter）、硝酸盐还原菌属（Nitratireductor）、公海橄榄菌属（Pelagibaca）、假海栖菌属（Pseudooceanicola）和海旋菌属（Thalassospira）。除了微泡菌属,其他8个属的细菌通过含油富集法分离获得,说明含油富集方法有利于发现新的产PHA细菌资源。此外,获得2株胞内PHA含量高的菌株。Nitratireductor aquimarinus SY-2-4在营养肉汤中培养可累积细胞干重35.0%的PHA;Roseibium aggregate SN13-21以丙酮酸盐为碳源,可累积细胞干重19.9%的PHA。[结论] 大鹏海域蕴藏着丰富的产PHA细菌资源,值得进一步挖掘研究。梯度增加含油量和盐度的富集方法有利于分离区系不同的产PHA细菌,适用于分离PHA资源。获得2株潜在PHA高产菌,未来将对菌株进行发酵优化研究。     

乌鳢源杀鱼爱德华菌的分离鉴定及药敏特性研究

[背景] 江苏省扬州市某乌鳢养殖场发生疾病,给养殖户造成了严重的经济损失。[目的] 确定病因并筛选出敏感药物,为乌鳢相关疾病的防治提供参考。[方法] 从患病乌鳢体内分离致病菌,并从形态、生理生化特征、16S rRNA和gyrB基因序列及特异性PCR检测等方面对分离菌株进行鉴定,同时开展人工感染试验分析其致病性,通过纸片扩散法进行药敏特性分析。[结果] 从患病乌鳢体内分离获得优势菌株SHL,经形态特征、理化特性、16S rRNA和gyrB基因序列及特异性PCR检测鉴定为杀鱼爱德华菌。进一步人工感染试验证实其对乌鳢有较强的致病性,LD₅₀为1.6×10⁵ CFU/g,发病症状与自然发病症状相似。药敏试验结果显示,该菌株对青霉素、氯霉素、四环素等28种抗菌药物高度敏感,对红霉素中度敏感,对苯唑西啉、克拉霉素、万古霉素等6种药物耐药。[结论] 引起江苏省扬州市某养殖场的乌鳢体表溃烂及死亡的病原菌为杀鱼爱德华菌,这是我国首次从淡水鱼类中检出致病性杀鱼爱德华菌,表明该菌的感染谱在扩大,需引起水产养殖领域的重视,在养殖过程中可根据药敏实验结果选用合适的国标渔药进行防治。     

降解1,3-二甲基-2-咪唑烷酮细菌的分离及功能评价

[背景] 1,3-二甲基-2-咪唑烷酮（1,3-Dimethyl-2-Imidazolidinone,DMI）作为一种强极性非质子溶剂,在生产和应用过程的环境中有稳定残留问题,存在安全隐患。[目的] 分离筛选具有降解DMI能力的微生物菌株,为清除环境中残留的DMI提供优良的微生物菌种资源。[方法] 从DMI生产区域土壤采集样品分离DMI抗性微生物,采用形态学及分子生物学鉴定确定其分类地位,并对DMI降解能力进行测定。[结果] 分离到最高能够耐受5%（体积分数） DMI的微生物菌株,形态学及分子生物学鉴定初步表明获得的菌株DT-1和DT-2为贝莱斯芽孢杆菌（Bacillus velezensis）;全细胞及细胞提取液均具有降解DMI的能力;其中菌株DT-1及其细胞提取液对1%（体积分数） DMI的降解率分别达到48%和68%。[结论] 从DMI生产区域土壤中分离到具有DMI降解能力的芽孢杆菌,不但可为DMI污染的微生物治理提供优良微生物资源,而且扩展了人们对芽孢杆菌生物学功能的认识。     

枯草芽孢杆菌中高效响应N-乙酰神经氨酸生物传感器的构建

枯草芽孢杆菌(Bacillus subtilis)是公认的食品安全菌株,目前已被用于多种高附加值产品的生物合成,包括被广泛用作营养化学品和药物中间体的N-乙酰神经氨酸(N-acetylneuraminic acid, NeuAc)。响应目标产物的生物传感器被广泛用于代谢工程中的动态调控和高通量筛选等方面,以提高生物合成效率。但是,枯草芽孢杆菌中缺乏可高效响应NeuAc的生物传感器。因此,本文首先测试和优化了能将胞外NeuAc转运进胞内的转运蛋白,获得了一系列具有不同转运能力的菌株,以用于后续响应NeuAc的生物传感器的验证;随后将响应NeuAc的转录因子Bbr_NanR的结合位点插入枯草芽孢杆菌组成型启动子的不同位置,筛选具有活性的杂合启动子;接下来,通过在具有NeuAc转运能力的枯草芽孢杆菌中表达Bbr_NanR,选择能响应NeuAc的杂合启动子,并进一步通过优化Bbr_NanR表达量获得了一系列动态范围广、激活倍数高的生物传感器,其中生物传感器P535-N2能灵敏地响应胞内NeuAc浓度的变化,具有最大的动态范围,为(180–20 245) AU/OD;P566-N2则具有最高的激活倍数,为122倍,是已报道的枯草芽孢杆菌中响应N-乙酰神经氨酸的生物传感器的2倍。本文构建的响应NeuAc的生物传感器可用于高产NeuAc的酶突变体和枯草芽孢杆菌菌株的筛选,为枯草芽孢杆菌生物合成NeuAc提供了高效、灵敏的分析和调控工具。     

Analysis of urinary N-acetyl-S-(N-methylcarbamoyl)cysteine, the mercapturic acid derived from N,N-dimethylformamide

Human biotransformation of the industrial solvent N,N-dimethylformamide gives raise to N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) which has the longest half-life (about 23 h) among urinary metabolites of N,N-dimethylformamide. It could be used for monitoring industrial exposure over several workdays, by measuring it in urine samples collected at the end of the working week. This is consistent with the suggestions of the American Conference of Governmental Industrial Hygienists, which established a limit of 40 mg/l for the year 2000. An easy, cheap and user-friendly method has been developed for determination of urinary AMCC. Unlike currently available methods, it requires neither a time-consuming preparation phase nor gas chromatographic analysis with a nitrogen-phosphorus or mass detector. The method uses high-performance liquid chromatography (HPLC), with an UV detector at 436 nm. A 10-μl volume of urine is added to a carbonate–hydrogen carbonate buffer and mixed with a dabsyl chloride solution in acetonitrile. The reaction between AMCC and the reagent is performed at 70°C for 10 min. The ‘dabsylated’ product is stable for at least 12 h. After brief centrifugation, the solution is ready for HPLC analysis using a C₁₈ column (250×4.6 mm, 5 μm). The method is sensitive (detection limit 1.8 mg/l) and specific. It identified urinary AMCC in urine of 40 subjects not exposed to N,N-dimethylformamide with a median concentration of 3.9 mg/l. In urine samples from 20 workers exposed to N,N-dimethylformamide (5–40.8 mg/m³), AMCC concentrations ranged from 16 to 170 mg/l. Industrial toxicology laboratories with limited instrumentation will be able to use it in the biological monitoring of workers exposed to N,N-dimethylformamide.     

Simultaneous determination of two human urinary metabolites of N,N-dimethylformamide using gas chromatography–thermionic sensitive detection with mass spectrometric confirmation

Two human urinary metabolites of the industrial solvent N,N-dimethylformamide (DMF), N-hydroxymethyl-N-methylformamide (HMMF) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC), were assayed using a new analytical method (gas chromatography and thermionic sensitive detection). Clean-up of urine samples includes a liquid–liquid extraction step followed by a solid-phase extraction step to separate HMMF and AMCC from other urine components. During clean-up, AMCC is converted into ethyl-N-methylcarbamate (EMC), and during gas chromatography, HMMF is degraded in the injector to N-methylformamide (NMF). All the validation data necessary for a quantitative procedure are given. The method was applied to urine samples from workers exposed to DMF and from the general population. The results were confirmed by mass spectrometric determination. For this purpose a further liquid–liquid extraction step was introduced in the clean-up procedure. Background levels of AMCC in the general population were identified.     

Coronatine analogues produced by Xanthomonas campestris pv Phormiicola

Liquid cultures of Xanthomonas campestris pv phormiicola were found to contain two analogues of coronatine lacking the cyclopropane ring structure, and no trace of either coronatine or norcoronatine. The two compounds were isolated and fully characterised by NMR, MS, hydrolysis and GC of hydrolysis products, as N-coronafacoyl- -valine and N-coronafacoyl- -isoleucine. A survey of 12 strains from 10 other X. campestris pathovars did not locate another source of production of these compounds, whereas all three strains of X. campestris pv phormiicola examined produced comparable levels of both compounds. This is the first report of phytotoxins biosynthetically derived from coronafacic acid outside of the genus Pseudomonas. The implications of these findings to the biosynthesis of the cyclopropane ring structure of coronatine are discussed.     

Radioenzymatic determination of CMP-N-acetylsialic acid and free N-acetylsialic acid in biological material

Free N-acetylsialic acid (NeuNAc) and CMP-N-acetylsialic acids (CMP-NeuNAc) are extracted from freeze-clamped or liquid nitrogen-frozen biological material by sequential extraction with cold acetone and acetone/water. [¹⁴C]NeuNAc and [¹⁴C]CMP-NeuNAc (20,000 dpm each) are added to the frozen material to correct for small losses occurring during the subsequent steps. NeuNAc and CMP-NeuNAc are separated by anion-exchange chromatography. CMP-NeuNAc is hydrolyzed with formic acid and again chromatographed on an ion-exchange column. The NeuNAc-containing fractions (representing free NeuNAc and CMP-NeuNAc) are converted to [¹⁴C]CMP-NeuNAc in the presence of [¹⁴C]CTP and CMP-NeuNAc synthetase. [¹⁴C]CMP-NeuNAc is separated by paper chromatography and the radioactivity measured by liquid scintillation counting. The amount of NeuNAc is calculated from a calibration curve obtained with NeuNAc standards. The small amounts of [¹⁴C]NeuNAc and [¹⁴C]CMP-NeuNAc added initially do not interfere with the final assay. The method gives reliable values down to 50 pmol/assay, but the sensitivity can be easily increased by a factor of 10. Recoveries, with NeuNAc and CMP-NeuNAc added to biological extracts, were 98.3 and 98.5% for NeuNAc and CMP-NeuNAc, respectively. With this method values of 61.2 ± 12.8 and 24.4 ± 5.2 nmol/g wet wt were found in rat liver for free NeuNAc and CMP-NeuNAc, respectively. Values for free NeuNAc found in human blood plasma were 600 ± 476 and 373 ± 180 pmol/g plasma for healthy persons and patients with breast cancer, respectively. Free CMP-NeuNAc could not be found in plasma.     

Simultaneous determination of pyridostigmine bromide, N,N-diethyl-m-toluamide, permethrin, and their metabolites in rat plasma and urine by high-performance liquid chromatography

A rapid and simple method was developed for the separation and quantification of the anti nerve agent drug pyridostignmine bromide (PB; 3-dimethylaminocarbonyloxy-N-methyl pyridinium bromide) its metabolite N-methyl-3-hydroxypyridinium bromide, the insect repellent DEET (N,N-diethyl-m-toluamide), its metabolites m-toluamide and m-toluic acid, the insecticide permethrin (3-(2,2-dichloro-ethenyl)-2,2-dimethylcyclopropanecarboxylic acid(3-phenoxyphenyl)methylester), and two of its metabolites m-phenoxybenzyl alcohol, and m-phenoxybenzoic acid in rat plasma and urine. The method is based on using C₁₈ Sep-Pak^® cartridges for solid-phase extraction (SPE) and high-performance liquid chromatography (HPLC) with reversed-phase C₁₈ column, and gradient UV detection ranging between 208 and 230 nm. The compounds were separated using gradient of 1 to 99% acetonitrile in water (pH 3.20) at a flow-rate ranging between 0.5 and 1.7 ml/min in a period of 17 min. The retention times ranged from 5.7 to 14.5 min. The limits of detection were ranged between 20 and 100 ng/ml, while limits of quantitation were 150–200 ng/ml. Average percentage recovery of five spiked plasma samples were 51.4±10.6, 71.1±11.0, 82.3±6.7, 60.4±11.8, 63.6±10.1, 69.3±8.5, 68.3±12.0, 82.6±8.1, and from urine 55.9±9.8, 60.3±7.4, 77.9±9.1, 61.7±13.5, 68.6±8.9, 62.0±9.5, 72.9±9.1, and 72.1±8.0, for pyridostigmine bromide, DEET, permethrin, N-methyl-3-hydroxypyridinium bromide, m-toluamide, m-toluic acid, m-phenoxybenzyl alcohol and m-phenoxybenzoic acid, respectively. The relationship between peak areas and concentration was linear over the range between 100 and 5000 ng/ml. This method was applied to analyze the above chemicals and metabolites following their administration in rats.     

Importance of high-performance liquid chromatographic analysis of serum N-acylneuraminic acids in evaluating surgical treatment in patients with early endometrial cancer

The objectives of this study were the quantification of the two major sialic acid (Sia) forms – N-acetylneuraminic (Neu5Ac) and N-glycolylneuraminic acids (Neu5Gc) – in serum before and after surgical treatment of early endometrial cancer and the relation of their levels with the progress of surgical therapy. The major Sia forms were liberated from sera glycoconjugates by mild acid hydrolysis, separated as per-O-benzoylated derivatives by a highly sensitive reversed-phase HPLC method and detected at 231 nm. Total Sia content in sera of healthy women was not related to age and body weight. Neu5Ac was identified as the major Sia in sera from both cancer patients, healthy individuals as well as in tissue specimens (≥94% of total Sia). In patients with endometrial cancer the total Sia level before surgical treatment (709.5±306.5 mg/l) was significantly higher (p≤0.0001) than that of the control group (213.5±88.7 mg/l). The elevation in Sia level was exclusively due to Neu5Ac. Following surgical therapy, serum Neu5Ac levels (699.4±305.6 mg/l) were significantly decreased (305.9±114.5 mg/l). In one case, where Neu5Ac level was increased 15 days and eight months after surgery (1.8 and 2.5 times as compared to control, respectively), a metastasis not detected during surgery was recorded. The obtained results suggest that Neu5Ac level in serum may be used as a tumor marker in evaluating the suitability of surgical treatment in early endometrial cancer.     

High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide

N-Acetylcysteine is a thiol antioxidant with expanding clinical importance. A sensitive, rapid method for determining reduced N-acetylcysteine (NAC) concentration in biological samples has been developed which uses a modified reversed-phase high-performance liquid chromatography (HPLC) technique in conjunction with the derivatizing agent N-(1-pyrenyl)maleimide (NPM). The NAC-NPM adduct was analyzed by HPLC with fluorescence detection. The calibration curve for NAC was linear over the range 8–2500 nM and the coefficient of variation obtained for the within-run precision and the between-run precision for 0.5 mM NAC was 1.5% and 2.7%, respectively. Relative recovery of NAC from biological materials ranged between 86% and 96% and the limit of quantitation from biological samples was 32 nM. These results suggest practical advantages relative to other widely-accepted methods of NAC measurement.     

Reversed-phase liquid chromatographic column switching for the determination of N-methylcarbamates and some of their main metabolites in urine

A column switching system for the determination of some polar pesticides and their main metabolites, such as aldicarb, aldicarb sulphoxide, aldicarb sulphone, carbofuran and 3-hydroxicarbofuran, in human urine has been developed. The limits of detection were between 0.3 and 1 μg/l. We used a simple solid-phase extraction with graphite carbon and a RPLC–LC analysis with UV detection yielding average recoveries between 84 and 110% (N=5) with RSD between 4 and 8%.     

Synthesis of N-monomethylagmatine, a decarboxylation product of N-monomethyl- -arginine

N^G-Monomethylagmatine, a decarboxylation product of N^G-monomethyl- -arginine, has been synthesized by reacting putrescine with N,S-dimethylthiopseudouronium iodide. The structural identity of the product was confirmed by proton NMR and mass spectroscopy, and its properties were determined on thin-layer and electrophoretic chromatography.     

Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine

A high-performance liquid chromatographic method for the determination of free reduced cysteine and N-acetylcysteine in human plasma at the basal state and after oral administration of N-acetylcysteine is described. The method is based on acid-catalysed conversion of plasma thiols to the corresponding S-nitroso derivatives by excess of nitrite and their subsequent cation-pairing RP-HPLC with detection at 333 nm. Recovery rates of cysteine and N-acetylcysteine added to human plasma were 94.6 and 99.6%, respectively. Inter- and intra-day precision were below 6%. In healthy humans (n=5), free reduced cysteine was determined to be (mean±S.E.) 10.0±0.96 μM. No N-acetylcysteine was detected in plasma of these subjects above the limit of detection (e.g. 170 nM). The method was successfully applied to a pharmacokinetic study on orally administered N-acetylcysteine to healthy volunteers.